NEW YORK, Nov. 14, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities Dynavax Technologies Corporation ("Dynavax" or the
"Company") (NASDAQ: DVAX). Such investors are advised to obtain
additional information and assist the investigation by visiting the
firm's site: www.bgandg.com/dvax.
The investigation concerns whether Dynavax and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On November 14, 2016, Dynavax
dropped over 62% on intraday trading after Dynavax announced that
it had received a Complete Response Letter from the U.S. Food and
Drug Administration, requesting additional information "including
clarification regarding specific adverse events of special interest
(AESIs), a numerical imbalance in a small number of cardiac events
in a single study (HBV-23), new analyses of the integrated safety
data base across different time periods, and post-marketing
commitments."
If you are aware of any facts relating to this investigation, or
purchased Dynavax shares, you can assist this investigation by
visiting the firm's site: www.bgandg.com/dvax. You can also contact
Peretz Bronstein or his Investor
Relations Analyst, Yael Hurwitz of
Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
Logo - http://photos.prnewswire.com/prnh/20161114/439152LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-dynavax-technologies-corporation-dvax-300362552.html
SOURCE Bronstein, Gewirtz & Grossman, LLC